Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32792862)

  • 1. Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis
    Chen YT; Huang CR; Chang CL; Chiang JY; Luo CW; Chen HH; Yip HK
    Int J Biol Sci; 2020; 16(14):2648-2662. PubMed ID: 32792862
    [No Abstract]   [Full Text] [Related]  

  • 2. Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation and Growth through Inhibiting PrP
    Yang CC; Chuang FC; Chang CL; Huang CR; Chen HH; Yip HK; Chen YT
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
    Chen YT; Yang CC; Shao PL; Huang CR; Yip HK
    J Pineal Res; 2019 Jan; 66(1):e12536. PubMed ID: 30372570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.
    Cheng TC; Din ZH; Su JH; Wu YJ; Liu CI
    Mar Drugs; 2017 Aug; 15(8):. PubMed ID: 28767067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells.
    Chen K; Zhu P; Chen W; Luo K; Shi XJ; Zhai W
    Aging (Albany NY); 2021 Sep; 13(18):22502-22515. PubMed ID: 34580235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
    Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valsartan- and melatonin-supported adipose-derived mesenchymal stem cells preserve renal function in chronic kidney disease rat through upregulation of prion protein participated in promoting PI3K-Akt-mTOR signaling and cell proliferation.
    Yang CC; Sung PH; Chen KH; Chai HT; Chiang JY; Ko SF; Lee FY; Yip HK
    Biomed Pharmacother; 2022 Feb; 146():112551. PubMed ID: 34923336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
    Costa C; Pereira S; Lima L; Peixoto A; Fernandes E; Neves D; Neves M; Gaiteiro C; Tavares A; Gil da Costa RM; Cruz R; Amaro T; Oliveira PA; Ferreira JA; Santos LL
    PLoS One; 2015; 10(11):e0141253. PubMed ID: 26569621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation.
    Seront E; Pinto A; Bouzin C; Bertrand L; Machiels JP; Feron O
    Br J Cancer; 2013 Sep; 109(6):1586-92. PubMed ID: 23989949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer.
    Yuge K; Kikuchi E; Hagiwara M; Yasumizu Y; Tanaka N; Kosaka T; Miyajima A; Oya M
    Mol Cancer Ther; 2015 Sep; 14(9):2112-20. PubMed ID: 26184482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
    Lin W; Xie J; Xu N; Huang L; Xu A; Li H; Li C; Gao Y; Watanabe M; Liu C; Huang P
    Int J Biol Sci; 2018; 14(4):418-426. PubMed ID: 29725263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
    Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
    Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Notch Signaling Promotes the Adipogenic Differentiation of Mesenchymal Stem Cells Through Autophagy Activation and PTEN-PI3K/AKT/mTOR Pathway.
    Song BQ; Chi Y; Li X; Du WJ; Han ZB; Tian JJ; Li JJ; Chen F; Wu HH; Han LX; Lu SH; Zheng YZ; Han ZC
    Cell Physiol Biochem; 2015; 36(5):1991-2002. PubMed ID: 26202359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways.
    Xiao W; Chen X; He M
    Mol Med Rep; 2014 Jul; 10(1):453-8. PubMed ID: 24805975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer.
    Li Y; Zhou Y; Huang M; Wang Z; Liu D; Liu J; Fu X; Yang S; Shan S; Yang L; Guo Y; Ren P; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X
    Cell Signal; 2023 Feb; 102():110553. PubMed ID: 36473621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
    Lv XY; Ma L; Chen JF; Yu R; Li Y; Yan ZJ; Cheng Y; Ma Q
    Int J Oncol; 2018 Jan; 52(1):288-294. PubMed ID: 29115412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.